Vertex Pharmaceuticals Q1 2023 Earnings Preview
Vertex Pharmaceuticals (NASDAQ:VRTX) is scheduled to announce Q1 earnings results on Monday, May 1st, after market close.
The consensus EPS Estimate is $3.02 (-14.2% Y/Y) and the consensus Revenue Estimate is $2.34B (+11.4% Y/Y).
Over the last 2 years, VRTX has beaten EPS estimates 88% of the time and has beaten revenue estimates 88% of the time.
Over the last 3 months, EPS estimates have seen 0 upward revisions and 9 downward. Revenue estimates have seen 5 upward revisions  and 5 downward.